Understand the clinical journey for patients with Psoriasis
Challenge
As objective disease severity scales (BSA, IGA) are not often collected in real-world clinical practice, longitudinal therapeutic escalation can serve as a good surrogate for disease severity.
Solution
Leverage OM1 linked, deep clinical and claims data to illustrate the longitudinal clinical treatment progression and associated outcomes.
*Counts through Q2 2022
PsO patients with diagnosis and deep clinical data including clinical notes from dermatologist
Patients with at least one PsO severity score